References
- Biollaz J, Schelling JL, Jacot Des Combes B, et al. (1982). Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system. Br J Clin Pharmacol 14:363–8
- Jackson T, Corke C, Agar J. (1993). Enalapril overdose treated with angiotensin infusion. Lancet 341:703
- Lau CP. (1986). Attempted suicide with enalapril. N Engl J Med 315:197
- McFate Smith W, Davies RO, Gabriel MA, et al. (1984). Tolerance and safety of enalapril. Br J Clin Pharmacol 18:249S–55S
- McFate Smith W, Kulaga SF, Moncloa F, et al. (1984). Overall tolerance and safety of enalapril. J Hypertens Suppl 2:S113–17
- Newby DE, Lee MR, Gray AJ, Boon NA. (1995). Enalapril overdose and the corrective effect of intravenous angiotensin II. Br J Clin Pharmacol 40:103–4
- Turini GA, Waeber B, Brunner HR. (1983). The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril. Eur Heart J 4:189–97
- Waeber B, Nussberger J, Brunner HR. (1984). Self poisoning with enalapril. Br Med J (Clin Res Ed) 288:287–8
- Webster J, Newnham D, Robb OJ, Petrie JC. (1987). Antihypertensive effect of single doses of enalapril in hypertensive patients treated with bendrofluazide. Br J Clin Pharmacol 23:151–7
- Weisser K, Schloos J, Lehmann K, et al. (1991). Pharmacokinetics and converting enzyme inhibition after morning and evening administration of oral enalapril to healthy subjects. Eur J Clin Pharmacol 40:95–9